Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors

Overview of attention for article published in PLOS ONE, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 4,754 followers.

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors. http://t.co/9i2csacUYT

@portefeuillefun @JSwatercooler @JohnCFierce preclinical #M002 data: hepatoblastoma, kidney tumor, and renal sarcoma http://t.co/f2Uekfc2Dl

$MDGEF €MDG1 #Medigene #oHSV: preclinical support for M032 in Pediatric Solid Tumors http://t.co/EQd8QnEJYh

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors #oHSV http://t.co/oEeJKomcVJ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.